Latest / Fuel for Female Founders® by Andrea L. Johnston / Patients, Purpose and Profits with Katherine Stueland | Ep 19
Transcript
- 0:00SPEAKER_00: Take the step forward, speak up, and believe in yourself.
- 0:04SPEAKER_00: Because if you wait for somebody else to do it, you're gonna be waiting.
- 0:07SPEAKER_00: There's no need to.
- 0:08SPEAKER_00: I had a a friend who said to me, think about all of the people who are believing in you and prove them to be right.
- 0:14SPEAKER_01: This is Fuel for Female Founders.
- 0:16SPEAKER_01: I'm your host, Andrea Johnston, and these are the real stories behind women's scaling, exiting, and investing.
- 0:23SPEAKER_01: Hi, everyone, and welcome back to Fuel for Female Founders.
- 0:27SPEAKER_01: Today's conversation is with someone I've had the pleasure of knowing for many years and who now leads in a whole new and exciting area of medicine.
- 0:36SPEAKER_01: Please join me in welcoming Catherine Stoolin, the president and CEO of Gene DX.
- 0:41SPEAKER_01: Catherine, it's so great to have you here.
- 0:42SPEAKER_00: Thank you so much.
- 0:43SPEAKER_00: It's so good to see you and to be here together in New York.
- 0:47SPEAKER_01: I know.
- 0:47SPEAKER_01: I have to say, I am so impressed with everything that you've accomplished, but also how important the mission of the work that you're doing really is.
- 0:56SPEAKER_01: And congratulations on your Time Health 100 this year.
- 0:59SPEAKER_01: That was awesome.
- 1:00SPEAKER_01: But to me, that's just a further testament to how important and how impactful the work that you and Gene DX are doing for patients.
- 1:08SPEAKER_00: Well, thank you so much.
- 1:10SPEAKER_00: I think all of the opportunities that I get to tell our story is on behalf of all of the families that we're trying to help.
- 1:19SPEAKER_00: There are so many parents out there really looking for answers for their children.
- 1:24SPEAKER_00: And it's also representative of the amazing team that we have working relentlessly to deliver those answers.
- 1:31SPEAKER_01: Well, it's so exciting because I think for many of our listeners out there who are women building in a career and wondering, you know, what's possible for me?
- 1:40SPEAKER_01: What could the future look like?
- 1:42SPEAKER_01: Or for women who are starting businesses and really kind of thinking about scaling and growing, you've done so many things that are relevant to them in your career.
- 1:51SPEAKER_01: And I'd love to start out with the fact that you're really, if I have this correct, an English major and a comms person by background.
- 1:57SPEAKER_01: And now you run a genomics company.
- 2:00SPEAKER_01: So talk about your journey.
- 2:02SPEAKER_00: Well, it's interesting to think back.
- 2:05SPEAKER_00: I'd like to think that my first brush with genomics actually was when I was 11.
- 2:10SPEAKER_00: And I learned that I had two cousins who had uh fatal genetic diseases.
- 2:16SPEAKER_00: So both of them had been diagnosed with cystic fibrosis, which back in the day that that was indeed a fatal diagnosis for most children in their teens.
- 2:25SPEAKER_00: Um, and so I learned about genetics way back then.
- 2:29SPEAKER_00: Um, and when I when I learned a little bit more, I also learned about the cystic fibrosis foundation and the work that they were doing to raise awareness, to raise money for research.
- 2:40SPEAKER_00: And so I started a fundraiser to try to raise money on behalf of um of those two cousins.
- 2:46SPEAKER_00: And so my roots really stem back to being a patient advocate.
- 2:51SPEAKER_00: And I feel like my career has had this consistent uh thread of being an advocate for different patients, whether it be at the time patients with HIV and AIDS, patients with depression and anxiety, um, patients with Huntington's disease, or in the past 15 years, really thinking about how we can advocate for everyone and how your DNA can inform so much more about your health than what most people realize.
- 3:19SPEAKER_01: And it's really, I feel like such an exciting time in science with what you, your company, and others are doing in the space.
- 3:26SPEAKER_01: And talk about when you first came to Gene DX.
- 3:28SPEAKER_01: Now you've been there what, five years?
- 3:30SPEAKER_01: It's been just over five years, yeah.
- 3:32SPEAKER_01: Oh my gosh.
- 3:33SPEAKER_01: But what was it like when you came?
- 3:35SPEAKER_01: How have things evolved?
- 3:37SPEAKER_00: Talk a little bit about that.
- 3:38SPEAKER_00: Yeah, Gene DX started at the NIH.
- 3:41SPEAKER_00: And so I like to think that we are kind of the picture perfect story of government-funded and founded science that is now helping um more and more families and doing it in a way that is generating um profitability so we can continue to reinvest.
- 3:58SPEAKER_00: Um, so the company's been around for 26 years.
- 4:01SPEAKER_00: Um, when I walked in uh just over five years ago, uh, a little bit of context, I came from California.
- 4:08SPEAKER_00: So I'd been living in San Francisco in the middle of the tech world, working in genomics.
- 4:14SPEAKER_00: Um, so environmentally, you know, open open offices and um snacks and people really working to get it was like the most, you know, California vibes.
- 4:31SPEAKER_00: And that becomes the norm.
- 4:33SPEAKER_00: And so when I moved uh to Maryland initially uh to take this job, it was during COVID.
- 4:40SPEAKER_00: So I had not entered the facility until day one.
- 4:43SPEAKER_00: Wow.
- 4:44SPEAKER_00: And so I I pulled up and the the building where we are and where we have been is a red brick building.
- 4:51SPEAKER_00: It seems almost like you're walking into like a school or a church in a sense.
- 4:56SPEAKER_00: Um there were offices with um, and you know, I think the the the visualization of it is is helpful.
- 5:04SPEAKER_00: It was like wood paneled furniture and landlines.
- 5:08SPEAKER_00: I was like, we didn't even have phones at my last day, you know, it was a retro.
- 5:11SPEAKER_00: Yeah, so retro.
- 5:13SPEAKER_00: Um, but what was really, really having the biggest impact on me after kind of the what am I walking into?
- 5:20SPEAKER_00: was um all of these cards and letters that were um that were on the walls of the of the facility.
- 5:29SPEAKER_00: And if you followed those those letters, they were all from parents to the founder of the company saying, thank you for diagnosing my son or my daughter with pictures and drawings and talking about the impact, many of them handwritten.
- 5:45SPEAKER_00: And so you kind of followed those letters.
- 5:47SPEAKER_00: And what was so breathtaking, that the prior company that owned the, that owned GDX had been investing in a modernization of the lab.
- 5:57SPEAKER_00: So you followed these letters from 25 years into it, it was almost like going from black and white into Technicolor.
- 6:05SPEAKER_00: And it was this beautiful modern lab.
- 6:08SPEAKER_00: And that's when it was like, we're gonna be able to take the power of this technology that's been built for decades now and bring it to so many more families.
- 6:18SPEAKER_00: So it was a bit of a culture shock in a sense.
- 6:21SPEAKER_00: Oh, I bet.
- 6:22SPEAKER_00: Um, but um, it really was the physical embodiment of what we've now been able to do by way of strategy, by way of culture, um, and by way of impact over the past five years.
- 6:34SPEAKER_01: So you really went from something that sounds like it was quite strong from a scientific perspective and really had to bring that business acumen, that ability to think about now, how do we make this into an actual business while keeping patients at the center?
- 6:46SPEAKER_00: That's exactly it.
- 6:47SPEAKER_00: It very much had that classic kind of academic, born in academia, really, really impressive clinical, technical, scientific rigor.
- 6:58SPEAKER_00: Um, that part they invested in.
- 7:01SPEAKER_00: And that, as you know, is like the most important part.
- 7:04SPEAKER_00: You want the confidence, you want the quality, um, you want the best experts who are working there.
- 7:10SPEAKER_00: The company had invested so beautifully in that.
- 7:14SPEAKER_00: And so, my job is to help us figure out how do we take this incredible foundation of clinical expertise.
- 7:22SPEAKER_00: 80% of clinical geneticists relied and continue to rely on Gene DX.
- 7:27SPEAKER_00: How do we take that and bring it to the masses?
- 7:31SPEAKER_01: So, five years in, five and a half years in, you look back, and I think I've even heard you say that you went from roles where you were often the number two, a strong and you know, very present number two, but number two nonetheless.
- 7:47SPEAKER_01: And there was a little bit of that feeling of imposter syndrome when you first thought about taking this job.
- 7:55SPEAKER_01: So, one, how did that feel?
- 7:58SPEAKER_01: And then secondly, now here you are five plus years later, what would you say to other women about that experience?
- 8:05SPEAKER_00: Well, I'll start with what I would say because I feel the sense of urgency.
- 8:10SPEAKER_00: Do it, step into that role.
- 8:13SPEAKER_00: Um, and I had been saying that to many other women and just made myself an exception.
- 8:18SPEAKER_00: You should go do it.
- 8:19SPEAKER_00: You're gonna be amazing.
- 8:22SPEAKER_00: Yeah.
- 8:23SPEAKER_00: Totally.
- 8:23SPEAKER_00: Um, but I had this moment when I got the call to say, would you be interested?
- 8:28SPEAKER_00: Where I said yes without, you know, really knowing is that a real yes or is it a yes to have a further exploration?
- 8:37SPEAKER_00: Um, which I would encourage anyone to just say yes and go for the exploration.
- 8:42SPEAKER_00: But then I realized in sitting as a right hand person to so many CEOs, one, it's not an easy spot.
- 8:52SPEAKER_00: You're when you're the right hand person or one of the right hand people, um, you have this immense set of responsibilities, but you never know exactly what it's like until you're in that role.
- 9:06SPEAKER_00: And so when I thought about it at the time, I thought I've been privileged like so many of us in this industry.
- 9:13SPEAKER_00: We are also mission-driven.
- 9:15SPEAKER_00: So does this company align with my values and my mission?
- 9:19SPEAKER_00: Yes.
- 9:20SPEAKER_00: But I also had witnessed what it was like to create great cultures, to create career opportunities for people.
- 9:27SPEAKER_00: Um, I had people who who took bets on me and gave me opportunities that that I wouldn't have been afforded otherwise.
- 9:35SPEAKER_00: Um, and so if I could step into a CEO role and and pay that forward to other people, what might be possible?
- 9:44SPEAKER_00: Um, so my my advice is to say go for it.
- 9:49SPEAKER_00: Um, because you're never gonna be 100% ready.
- 9:52SPEAKER_00: The the idea of being 100% ready for anything is a fallacy.
- 9:55SPEAKER_01: Fallacy, I agree.
- 9:57SPEAKER_01: Yeah.
- 9:57SPEAKER_01: But it is something I think we all hold ourselves to the standard.
- 10:00SPEAKER_01: And I think that's something also uniquely female, where we think we have to check all the boxes.
- 10:05SPEAKER_01: Um, so I love that you share that advice with our listeners.
- 10:09SPEAKER_01: I also wonder, I mean, given the success that Gene DX has experienced over the last five plus years and where you've taken the company and where the team has taken the company, process, people, all the things that it requires to scale and to successfully grow a company, especially a public company, where you have the added element of the public markets and the scrutiny and all of that.
- 10:32SPEAKER_01: Talk to us about that scaling and growing and what perspective you now have given what you've experienced over the last several years.
- 10:42SPEAKER_00: You know, when I look back in 2021, we did about$116 million in revenue.
- 10:48SPEAKER_00: Um, in 2025, we did about$427 million in revenue.
- 10:52SPEAKER_00: Congratulations.
- 10:53SPEAKER_00: Thank you.
- 10:54SPEAKER_00: It has been uh every patient sample, every family that we've served, um, every every dollar that we've been able to bring in for the services that we're providing has been hard, hard served and hard fought by our entire team.
- 11:12SPEAKER_00: Um, what keeps us going is the number of patients that that we can impact.
- 11:17SPEAKER_00: So we talk about our North Star as being um helping as many families as quickly as possible.
- 11:23SPEAKER_00: The reason why that's so important, it still takes on average five years for a child with a rare disease to get an accurate diagnosis.
- 11:30SPEAKER_00: Five years, even today.
- 11:32SPEAKER_00: Even today, where we can do a genome, we can run and interpret a genome in 48 hours.
- 11:36SPEAKER_00: And it's taking five years.
- 11:38SPEAKER_00: It still takes five years.
- 11:40SPEAKER_00: And there's a whole litany of reasons and conversations that we need to change because we've generated so much data, whether it's clinical data or health economic data.
- 11:50SPEAKER_00: Um, but as I think about the processes, as I think about the ability to scale, um you know, one mission is so important.
- 12:00SPEAKER_00: And keeping that North Star, every employee meeting that we have and every investor meeting, we talk about that as being our North Star.
- 12:08SPEAKER_00: Um and everything kind of falls from there.
- 12:11SPEAKER_00: Um, but I would say it we've had, and I kind of think of this as the we've we've been living a Netflix show.
- 12:18SPEAKER_00: Um each each year has been a different season.
- 12:22SPEAKER_00: And um, and so I think that could happen.
- 12:25SPEAKER_01: Maybe you need to do that Instagram reel that everybody's doing these days on waiting for my Netflix series.
- 12:32SPEAKER_00: Who's gonna play who?
- 12:33SPEAKER_00: Yeah.
- 12:34SPEAKER_00: Um, but each year has been a different, a different job.
- 12:38SPEAKER_00: It's been a different, um, it's been a different uh strategy that we've had to deploy.
- 12:44SPEAKER_00: Um and as I think about the the work from uh private to public, one of the biggest areas of focus for us was like, why should everyone care about profitability?
- 12:55SPEAKER_00: Like we we were on this.
- 12:57SPEAKER_00: Um, the first question I was asked when I interviewed, do you have any interest in making a company profitable?
- 13:02SPEAKER_00: And I said, yes.
- 13:03SPEAKER_00: So the the reason why that's so important is because it means we can help more patients.
- 13:09SPEAKER_00: So our our continued waterline is never sacrifice on quality, never sacrifice on clinical expertise.
- 13:18SPEAKER_00: And you have to have a healthy business so you can reinvest and help more and more patients.
- 13:22SPEAKER_00: And you can reinvest to improve your technology.
- 13:26SPEAKER_00: Um, and so as we moved from private to public, it was it was this journey of why does financial acumen matter to you?
- 13:35SPEAKER_00: Right.
- 13:35SPEAKER_00: Right.
- 13:35SPEAKER_00: And and so our CFO did an amazing job, by the way, of educating people.
- 13:41SPEAKER_00: And communication was a huge part of how we got people on board with it.
- 13:45SPEAKER_00: Every all hands, um, we would we would talk about the path to profitability, we would talk about our financial dashboards.
- 13:54SPEAKER_00: And uh as as good academics, as great commercial people too, everyone really got on board in this team sport to say, we're gonna go prove to everyone that we can do it.
- 14:07SPEAKER_00: So um it's been, it's been different processes, it's been different structures, it's been different people, depending on what chapter or season we're in.
- 14:17SPEAKER_00: Um, but kind of having hypervigilance on what's working, what's not working, because there's always something that isn't working that's lurking in the background and kind of looking around the corner and uncovering that to figure out, okay, what are the changes and processes that we need to deploy that requires hypervigilance?
- 14:37SPEAKER_01: I'm so glad that you shared that because I think sometimes founders, especially earlier mid-stage founders or operators that are leading private, smaller companies, they think the public companies have it all figured out.
- 14:51SPEAKER_01: But so much of what you talked about are things that all of us, no matter what size company we are running, we face those same seasons and chapters to our business.
- 15:00SPEAKER_01: We experience different challenges that require different solutions, different talent at different times, org structures, et cetera.
- 15:07SPEAKER_01: So I'm really glad you verbalize that because I think it's something everyone needs to hear.
- 15:12SPEAKER_01: Because it's part of, in my mind, what's so exciting about leading is you're always facing some new challenge, but also opportunity.
- 15:20SPEAKER_01: And it's how you meet that moment.
- 15:22SPEAKER_00: I like to remind people that our jobs are to solve problems.
- 15:26SPEAKER_00: And so um, it can feel like that's all you're doing all day long, and it can feel so unique to you.
- 15:33SPEAKER_00: I just shared with our management team a chart because we've been in hypergrowth.
- 15:38SPEAKER_00: We're now in a phase of how do you balance hypergrowth with infrastructure for a 26-year-old company?
- 15:45SPEAKER_00: How do you really make sure that you have the processes and structure in place to then I don't want to say arrive at an easier place of volume and revenue coming in, but um, being able to just have that, that, the velocity that you're looking for.
- 16:02SPEAKER_00: And if you look at exact sciences, if you look at Gardens, if you look at Amazon, if you look at Netflix, they all go through a period of hypergrowth, of investing in infrastructure and then coming out on the other side.
- 16:14SPEAKER_00: So I like to remind people one, solving problems is the reason that we're all here.
- 16:20SPEAKER_00: Um, and two, it feels all of it, the problems that we face, the challenges that we face, all feels so personal and unique to us.
- 16:29SPEAKER_00: But realistically, it's what every successful company goes through at some point in time.
- 16:33SPEAKER_01: And you're right, the successful companies are the ones that figure out how to innovate and how to stay ahead.
- 16:38SPEAKER_01: And as you said, look around those corners to get ahead of whatever's next.
- 16:42SPEAKER_01: Which brings me to one of my next questions, which is as you look forward, as you look at how far the science has come, as you look at how far Gene DX has come, I just think about how much there's greater patient awareness.
- 16:55SPEAKER_01: We still have so many challenges from a reimbursement and broader healthcare delivery standpoint.
- 16:59SPEAKER_01: But when you really look ahead, what is getting you most excited about the future, especially in genomics?
- 17:07SPEAKER_00: You know, what's what's really gratifying is the technology is there today.
- 17:11SPEAKER_00: As I said, we can interpret a genome in 48 hours.
- 17:15SPEAKER_00: And so I feel like, in a sense, we've got this superpower that we just need every parent to know about and every pediatrician to know about.
- 17:23SPEAKER_00: Um, but right now with AI and um so much investment and focus going into healthcare, um, I think everyone sees that there is a better future.
- 17:35SPEAKER_00: I think everyone sees that there is the ability to go from waiting for everyone to be sick and sicker to how do we use this information more proactively and preventively.
- 17:46SPEAKER_00: Um, we're focused on children who are sick today.
- 17:49SPEAKER_00: That's mainly in the outpatient setting.
- 17:51SPEAKER_00: It's in the NICU, but we've also done the largest uh newborn screening study uh using whole genome sequencing here in New York State.
- 18:00SPEAKER_00: And uh we have the first state in Florida um that passed a law regarding newborn screening.
- 18:07SPEAKER_00: So I like to say Florida is the most progressive state when it comes to child genomic screening.
- 18:13SPEAKER_00: That's amazing.
- 18:14SPEAKER_00: So we're seeing these advances and the the work that we've done here in New York has shown that 3.2% of healthy babies actually have a clinically actionable genetic condition.
- 18:27SPEAKER_00: And so we went to take a look to say, you know, for the diseases that we're now discovering um within weeks of birth, what was the average age of diagnosis in our 25-year history?
- 18:40SPEAKER_00: And it was seven to eleven years.
- 18:44SPEAKER_00: And so when you think about eradicating seven to eleven years of unnecessary disease progression, all of the costs from a from the parents' perspective, these families um, you have so much lost productivity for the parents.
- 18:57SPEAKER_00: You have parents who abandon their careers, many who go into medical bankruptcy, you have a higher rate of depression, anxiety for the child and the parents, you have a higher rate of divorce.
- 19:08SPEAKER_00: And so what we're trying to solve is not um while trying to protect a child's health is number one the most important priority.
- 19:18SPEAKER_00: This is a total family health crisis that could be avoidable if we started using this information so much earlier.
- 19:26SPEAKER_00: And in addition to providing better health outcomes for the child and the parents, um, we can actually save the healthcare system so much money.
- 19:35SPEAKER_01: I mean, it's really incredible.
- 19:36SPEAKER_01: And I I hope that what we're seeing in Florida and New York, more states catch on and you can see that replicated because in addition to everything you just described, I can imagine that the emotional and the anxiety, all of that, when it's better to have an answer and know what you're dealing with than to live in that uncertainty and just be going to the next doctor's appointment and the next doctor's appointment, right?
- 19:59SPEAKER_01: So all of those things that you described, this is such an important step, step to solving those bigger problems.
- 20:06SPEAKER_00: That conversation is actually one of the most important conversations that we need to have because one of the reasons why you might have a doctor who doesn't order testing is because they'll say 95% of the time there's not an FDA-proof therapy.
- 20:21SPEAKER_00: Um you have broad insurance coverage and medical policy supporting um supporting payment for these sorts of services and supporting access for these services.
- 20:34SPEAKER_00: But you also have some payers who will say, I don't know if providing an answer without an FDA-approved therapy is the very best thing for a parent or for the child.
- 20:43SPEAKER_00: Now, I can tell you from 100% of the conversations I've had with parents who um are fighting for their children, um, there is an immense amount of guilt that is alleviated on the part of the mom.
- 20:57SPEAKER_01: I can imagine.
- 20:58SPEAKER_00: Um, because they in this diagnostic odyssey are stuck with um sometimes an unspoken worry.
- 21:05SPEAKER_00: And that unspoken worry is causing depression and anxiety of what is it that I did.
- 21:10SPEAKER_00: So to know that it was something that was genetic is hugely important to connect with other families, to be in community with other families, to learn from other families who have a child with that same mutation is incredibly powerful.
- 21:24SPEAKER_00: Um, and it can be the difference between um having that accurate diagnosis.
- 21:28SPEAKER_00: It can be the difference between, you know, I'm there, it's not worth it for us to invest in speech therapy.
- 21:35SPEAKER_00: And we've been going to speech therapy, but my daughter is not going to benefit from it.
- 21:39SPEAKER_00: And how frustrating for a child to be going to speech therapy and it not render any benefit.
- 21:45SPEAKER_00: So there's so many other steps that can be taken short of that FDA approved therapy.
- 21:52SPEAKER_00: But we also want to see how we might be able to change those stats.
- 21:56SPEAKER_00: Um, you have so many parents who do leave their jobs to become CEO of a biotech company, right?
- 22:02SPEAKER_00: So they're out there with this sense of purpose and urgency and efficiency to try to change those stats.
- 22:09SPEAKER_01: Yeah, I was just actually speaking to a woman recently who started the Rhett Syndrome Research Trust.
- 22:16SPEAKER_01: And, you know, same situation where her daughter was diagnosed and it put her on this mission and she's really made it her life's work.
- 22:25SPEAKER_01: So I feel like having that answer, even if you don't have the immediate solution, does provide in that sense of community that you spoke of and being able to connect with other families and caregivers.
- 22:36SPEAKER_01: And this is why diagnostic testing is so important and genomic testing is so important.
- 22:42SPEAKER_01: Um, so I'm really glad that you're here to share this and help educate us.
- 22:46SPEAKER_01: As you look at where you've been, where you're going, the women, because of the role you now hold, that you've been able to meet and connect with, what are your three kind of key takeaways for women leading in this era?
- 23:02SPEAKER_00: Take the step forward, speak up and believe in yourself.
- 23:07SPEAKER_00: Because if you wait for somebody else to do it, you're gonna be waiting.
- 23:10SPEAKER_00: There's no need to.
- 23:11SPEAKER_00: I had a friend who said to me, think about all of the people who are believing in you and prove them to be right.
- 23:17SPEAKER_00: And I love that.
- 23:18SPEAKER_00: Love that.
- 23:19SPEAKER_00: Because it's such a good flip on um like prove prove everyone wrong.
- 23:22SPEAKER_00: It's like there are so many people who do believe in you.
- 23:25SPEAKER_00: But at the end of the day, imposter syndrome is something men and women do face it.
- 23:30SPEAKER_00: I I think women tend to talk about it more.
- 23:33SPEAKER_00: And I think it can help break down the barriers there.
- 23:36SPEAKER_00: But um, but just continue to believe in yourself.
- 23:39SPEAKER_01: Awesome.
- 23:40SPEAKER_01: Well, Catherine, thank you so much.
- 23:42SPEAKER_01: Thank you for those additional words of wisdom.
- 23:44SPEAKER_01: Thank you all for being here to listen to this conversation.
- 23:47SPEAKER_01: We hope you will tune in next time.
- 23:49SPEAKER_01: And if you would like to know more about Catherine and her work, what's the best place to find you from a social media perspective?
- 23:54SPEAKER_00: LinkedIn.
- 23:55SPEAKER_01: LinkedIn.
- 23:56SPEAKER_01: Yeah.
- 23:56SPEAKER_01: All right.
- 23:57SPEAKER_00: Keep it simple.
- 23:58SPEAKER_01: I love it.
- 23:58SPEAKER_01: Well, follow along on the Gene DX journey and Catherine's own leadership journey through LinkedIn.
- 24:04SPEAKER_01: Thank you again.
- 24:05SPEAKER_01: Thank you so much.
- 24:06SPEAKER_01: If we're not already connected on LinkedIn, I'd love to be connected.
- 24:10SPEAKER_01: You can find me under Andrea Johnston.
- 24:12SPEAKER_01: That's where I post podcast clips, conversations with other female entrepreneurs, and updates from our Fuel for Female Founders, the Features series.